17-42536630-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000263.4(NAGLU):c.358G>T(p.Glu120*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000371 in 1,347,404 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000263.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAGLU | NM_000263.4 | c.358G>T | p.Glu120* | stop_gained | Exon 1 of 6 | ENST00000225927.7 | NP_000254.2 | |
NAGLU | XM_024450771.2 | c.358G>T | p.Glu120* | stop_gained | Exon 1 of 7 | XP_024306539.1 | ||
NAGLU | XM_047436138.1 | c.-104G>T | 5_prime_UTR_variant | Exon 1 of 5 | XP_047292094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAGLU | ENST00000225927.7 | c.358G>T | p.Glu120* | stop_gained | Exon 1 of 6 | 1 | NM_000263.4 | ENSP00000225927.1 | ||
NAGLU | ENST00000586516.5 | c.107G>T | p.Gly36Val | missense_variant | Exon 1 of 4 | 2 | ENSP00000467135.1 | |||
NAGLU | ENST00000591587.1 | c.101G>T | p.Gly34Val | missense_variant | Exon 1 of 4 | 5 | ENSP00000467836.1 | |||
ENSG00000266929 | ENST00000585572.1 | n.121G>T | non_coding_transcript_exon_variant | Exon 1 of 5 | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000371 AC: 5AN: 1347404Hom.: 0 Cov.: 30 AF XY: 0.00000452 AC XY: 3AN XY: 664274
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Mucopolysaccharidosis, MPS-III-B Pathogenic:3
Variant summary: NAGLU c.358G>T (p.Glu120X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 96200 control chromosomes (gnomAD). c.358G>T has been reported in the literature in multiple individuals affected with Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome B) (Whitley_2018, Truxal_2016, Pollard_2013, Piotrowska_2008). These data indicate that the variant is very likely to be associated with disease. No enzymatic activity was found in a patient derived sample who was compound heterozygous for the variant of interest and another possible pathogenic variant (Pollard_2013). Two ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
Mucopolysaccharidosis, MPS-III-B;C5569050:Charcot-Marie-Tooth disease axonal type 2V Pathogenic:1
This sequence change creates a premature translational stop signal (p.Glu120*) in the NAGLU gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAGLU are known to be pathogenic (PMID: 9832037, 10094189, 16151907). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with mucopolysaccharidosis type III (PMID: 19046346, 27590925, 29661560). ClinVar contains an entry for this variant (Variation ID: 552642). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at